Croatian Croatian
en Englishaf Afrikaanssq Albanianar Arabichy Armenianaz Azerbaijanieu Basquebe Belarusianbg Bulgarianca Catalanzh-CN Chinese (Simplified)zh-TW Chinese (Traditional)hr Croatiancs Czechda Danishnl Dutchet Estoniantl Filipinofi Finnishfr Frenchgl Galicianka Georgiande Germanel Greekht Haitian Creoleiw Hebrewhi Hindihu Hungarianis Icelandicid Indonesianga Irishit Italianja Japaneseko Koreanlv Latvianlt Lithuanianmk Macedonianms Malaymt Malteseno Norwegianfa Persianpl Polishpt Portuguesero Romanianru Russiansr Serbiansk Slovaksl Slovenianes Spanishsw Swahilisv Swedishth Thaitr Turkishuk Ukrainianur Urduvi Vietnamesecy Welshyi Yiddish

Najnovije vijesti

FDA liftovi zadržavaju uniQureov program genske terapije hemofilije B.

 

Roctavian, potencijalna hemofilija genetska terapija, dobiti svježu podršku FDA

 

Genska terapija hemofilije B AMT-061 Malo je vjerojatno da je uzrokovala tumor jetre

 

Genska terapija SPK-8016 daje rano obećanje za tešku hemofiliju A

 

Povratak na vrh
Slika

Please enable the javascript to submit this form

O nama

Podržano obrazovnim grantovima Bayer -a, BioMarina, Freeline Therapeutics Limited, Pfizer Inc., Shire, Spark Therapeutics i uniQure, Inc.

Osnovni SSL